Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Cash from Operations (2016 - 2026)

Corvus Pharmaceuticals' Cash from Operations history spans 12 years, with the latest figure at 10374000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 25.55% to 10374000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 34908000.0 through Mar 2026, down 22.36% year-over-year, with the annual reading at 32797000.0 for FY2025, 29.0% down from the prior year.
  • Cash from Operations came in at 10374000.0 for Q1 2026, down from 9191000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 5157000.0 in Q1 2024 to a low of 10374000.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 6424000.0 (2022), against an average of 7032529.41.
  • Year-over-year, Cash from Operations surged 51.59% in 2022 and then crashed 63.83% in 2024.
  • Corvus Pharmaceuticals' Cash from Operations stood at 7547000.0 in 2022, then skyrocketed by 31.54% to 5167000.0 in 2023, then crashed by 63.83% to 8465000.0 in 2024, then fell by 8.58% to 9191000.0 in 2025, then decreased by 12.87% to 10374000.0 in 2026.
  • Per Business Quant, the three most recent readings for CRVS's Cash from Operations are 10374000.0 (Q1 2026), 9191000.0 (Q4 2025), and 9566000.0 (Q3 2025).